Integrated Quantitative Investments LLC
Position in TBPH — Theravance Biopharma, Inc.
CIK 2046834
BELLEVUE, WA
Position in TBPH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$806,777
-$1,160,448 QoQ
Shares Held
49,709
-52.7% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Integrated Quantitative Investments LLC holds $4,437,657 across 11 Biotechnology names. TBPH ranks #2 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
36,355 | $975,404 | |
| 2 | TBPH |
Theravance Biopharma, Inc.
This page
|
49,709 | $806,777 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,192 | $488,910 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
1,253 | $403,704 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
5,842 | $366,293 | |
| 6 | ALMS |
Alumis Inc.
|
15,423 | $339,768 | |
| 7 | ANAB |
Anaptysbio, Inc
|
5,606 | $310,908 | |
| 8 | ZVRA |
Zevra Therapeutics, Inc.
|
33,315 | $310,495 |
All Filings in TBPH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $806,777 | 49,709 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,967,225 | 105,143 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $367,511 | 25,172 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||